salicylic acid and plx4032

salicylic acid has been researched along with plx4032 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gómez Fernández, C; Nieto Rodríguez, D; Rueda Carnero, JM1
Gerami, P; Martini, M; Sorrell, J1
Arenberger, P; Arenbergerova, M; Fialova, A; Horazdovsky, J; Mrazova, I; Sticova, E1

Other Studies

3 other study(ies) available for salicylic acid and plx4032

ArticleYear
Facial spiny follicular hyperkeratosis induced by vemurafenib.
    The Journal of dermatology, 2018, Volume: 45, Issue:2

    Topics: Aged; Antineoplastic Agents; Diagnosis, Differential; Face; Female; Humans; Keratosis; Melanoma; Salicylic Acid; Skin; Skin Neoplasms; Treatment Outcome; Urea; Vemurafenib; Warts

2018
Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib.
    Journal of the American Academy of Dermatology, 2012, Volume: 67, Issue:6

    Topics: Dermoscopy; Dysplastic Nevus Syndrome; Humans; Indoles; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Scalp; Skin Neoplasms; Sulfonamides; Vemurafenib

2012
Toxic epidermal necrolysis induced by vemurafenib after nivolumab failure.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:5

    Topics: Antineoplastic Agents; Biopsy; Female; Humans; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Nivolumab; Scalp; Skin; Skin Neoplasms; Stevens-Johnson Syndrome; Treatment Failure; Vemurafenib

2017